Cellosaurus IVR02 (CVCL_E5FU)
Cell line name | IVR02 |
---|---|
Synonyms | In Vivo Resistant 02 |
Accession | CVCL_E5FU |
Resource Identification Initiative | To cite this cell line use: IVR02 (RRID:CVCL_E5FU) |
Comments | Population: Caucasian. Characteristics: Female nude mice were injected IP with the parent cell line. Once tumours were established the mice were treated with carboplatin. This cell line was establishe from one of these in-vivo established resistant tumor cells (PubMed=35918200). Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin). Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Firefly luciferase. Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. |
Sequence variations |
|
Disease | High grade ovarian serous adenocarcinoma (NCIt: C105555) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_E5FK (OVCAR4-Luc) |
Sex of cell | Female |
Age at sampling | 42Y |
Category | Cancer cell line |
Publications | PubMed=35918200; DOI=10.1016/j.ygyno.2022.07.027 |
Entry history | |
Entry creation | 10-Apr-2025 |
Last entry update | 10-Apr-2025 |
Version number | 1 |